TERN - Terns Pharmaceuticals, Inc.

QQQ $ 610.86 $ -0.16 (-0.03 %)

DIA $ 469.35 $ 2.20 (0.47 %)

SPY $ 671.30 $ -0.01 (0 %)

TLT $ 92.05 $ 0.45 (0.49 %)

GLD $ 379.20 $ -25.91 (-6.43 %)

Previous Close

$ 8.12

Open

$ 8.43

Bid

$ 6.96 x 100

Ask

$ 7.20 x 1,691

Day's Range

$ 7.90 - $ 8.63

52 Week Range

$ 1.87 - $ 9.03

Volume

2,652,376

Average Volume

Market Cap

710.59M

Beta (5Y Monthly)

$ 0.95

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-05-2025	06-30-2025	10-Q
2	05-08-2025	03-31-2025	10-Q
3	03-20-2025	12-31-2024	10-K
4	11-12-2024	09-30-2024	10-Q
5	08-05-2024	06-30-2024	10-Q
6	05-13-2024	03-31-2024	10-Q
7	03-14-2024	12-31-2023	10-K
8	11-14-2023	09-30-2023	10-Q
9	08-08-2023	06-30-2023	10-Q
10	05-15-2023	03-31-2023	10-Q
11	03-27-2023	12-31-2022	10-K
12	11-09-2022	09-30-2022	10-Q
13	08-08-2022	06-30-2022	10-Q
14	05-16-2022	03-31-2022	10-Q
15	03-07-2022	12-31-2021	10-K
16	11-15-2021	09-30-2021	10-Q
17	08-16-2021	06-30-2021	10-Q
18	05-14-2021	03-31-2021	10-Q
19	03-30-2021	12-31-2020	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

12 Health Care Stocks Moving In Tuesday's ...
10/21/2025 21:06:33

Terns Pharmaceuticals Halts Development Of...
10/21/2025 20:27:26

Terns Pharma Reports Topline 12-Week Resul...
10/21/2025 20:09:01

Results show maximum placebo-adjusted weight loss of 4.6% with 12% treatment discontinuation due to adverse eventsAsymptomatic,...

Truist Securities Initiates Coverage On Te...
10/15/2025 11:33:58

Truist Securities analyst Srikripa Devarakonda initiates coverage on Terns Pharma (NASDAQ:TERN) with a Buy rating and announ...

Barclays Initiates Coverage On Terns Pharm...
09/17/2025 11:05:06

Barclays analyst Etzer Darout initiates coverage on Terns Pharma (NASDAQ:TERN) with a Overweight rating and announces Price ...

HC Wainwright & Co. Assumes Terns Pharma a...
09/04/2025 11:30:14

HC Wainwright & Co. analyst Andrew S. Fein assumes Terns Pharma (NASDAQ:TERN) with a Neutral rating and announces Price ...

eli-lillys-rare-weight-loss-data-miss-could-benefit-competitors

Eli Lilly's Rare Weight Loss Data Miss Cou...
08/07/2025 13:55:46

Eli Lilly's obesity drug data misses targets, boosting shares of Novo Nordisk, Viking, Structure, and Terns amid promising ...

Terns Pharma Q2 EPS $(0.26) Beats $(0.30) ...
08/05/2025 20:33:06

Terns Pharma (NASDAQ:TERN) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.30) ...

Terns Pharma Says Phase 2 FALCON Clinical ...
06/23/2025 20:10:16

Terns Pharma To Highlight Data From Comple...
06/23/2025 20:09:19

Phase 1 clinical study of TERN-601 demonstrated differentiated profile in 28-day study; topline data were presented in Septembe...

12 Health Care Stocks Moving In Friday's P...
06/20/2025 12:09:39

insmed-tesla-caseys-general-stores-and-other-big-stocks-moving-higher-on-tuesday

Insmed, Tesla, Casey's General Stores And ...
06/10/2025 14:18:02

Terns Pharmaceuticals Selected For Oral Pr...
05/14/2025 13:44:39

Preclinical data highlight improved potency vs. asciminib across multiple clinically relevant variants of BCR-ABL including dif...

BMO Capital Maintains Outperform on Terns ...
05/13/2025 16:46:35

BMO Capital analyst Etzer Darout maintains Terns Pharma (NASDAQ:TERN) with a Outperform and lowers the price target from $26...

Terns Pharma Q1 EPS $(0.26) Beats $(0.28) ...
05/08/2025 21:02:19

Terns Pharma (NASDAQ:TERN) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.28) ...

JMP Securities Reiterates Market Outperfor...
04/21/2025 16:32:35

JMP Securities analyst Silvan Tuerkcan reiterates Terns Pharma (NASDAQ:TERN) with a Market Outperform and maintains $20 pric...

Terns Pharma Q4 2024 GAAP EPS $(0.24) Beat...
03/20/2025 20:17:26

Terns Pharma (NASDAQ:TERN) reported quarterly losses of $(0.24) per share which beat the analyst consensus estimate of $(0.30) ...

William Blair Initiates Coverage On Terns ...
02/28/2025 12:08:59

William Blair analyst Andy Hsieh initiates coverage on Terns Pharma (NASDAQ:TERN) with a Market Perform rating.

Terns Pharmaceuticals Appoints Andrew Geng...
02/24/2025 21:13:18

Terns Pharmaceuticals, Inc. ("Terns" or the "Company") (NASDAQ:TERN), a clinical-stage biopharmaceutical compan...

FDA Says Novo Nordisk's Ozempic Injection ...
02/21/2025 14:22:44